Coverage Decisions for Expensive Hemophilia Treatments
Russell P. Gollard, MD, FACP, discusses coverage decisions for expensive treatments in hemophilia, including total cost of care, drug availability, and real-world evidence.
Source: ajmc.com
Stay updated with breaking news from Side Effects Prevention. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Russell P. Gollard, MD, FACP, discusses coverage decisions for expensive treatments in hemophilia, including total cost of care, drug availability, and real-world evidence.